Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | EVP and CFO | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,354 | -- | 133,949 | |
| Aug 12, 2021 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,387 | -- | 378,554 | |
| Aug 15, 2006 | VP - Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,600 | -- | 19,600 | |
| Aug 06, 2013 | CTO and COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,723 | -- | 19,723 | |
| Sep 12, 2017 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 19,776 | $18.09 | 45,288 | |
| Jul 14, 2020 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,800 | -- | 19,800 | |
| Jul 12, 2019 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- | |
| Jul 20, 2017 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,000 | $15.64 | 86,683 | |
| Aug 18, 2016 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 | |
| Oct 17, 2013 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $11.00 | 35,850 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.